自拍视频精品,97国产色,亚洲另类校园春色,亚洲久久天堂,99精品在线免费,久久久久久久久久久免费av,天天做天天躁天天躁

From October 28–30, the world’s leading pharmaceutical exhibition, CPHI Frankfurt 2025, successfully concluded in Frankfurt, Germany. YINO Biologic made a remarkable appearance at the event, presenting a range of green solvents and raw materials designed for the pharmaceutical industry, and showcasing cutting-edge innovations in biobased technology that drive sustainable pharmaceutical development. In pharmaceutical manufacturing, the choice of solvents and raw materials not only determines process safety and environmental performance but also directly affects product purity and production efficiency. YINO Biologic utilizes non-food biomass corncob as its primary raw material, achieving carbon reduction and resource efficiency from the very beginning. The company has established a green supply chain covering the entire process from raw materials to end products. At the exhibition, YINO highlighted several high-performance sustainable products, including 2-Methyltetrahydrofuran (2-MeTHF) — a green solvent for active pharmaceutical ingredient (API) synthesis that effectively replaces traditional THF, significantly reduces volatile organic compound emissions, and enhances both reaction safety and efficiency; 3,4-Dihydro-2H-Pyran (DHP) — a key intermediate for high-end protecting groups and fine chemical synthesis; and δ-Valerolactone (δ-VL) — a next-generation high-purity cyclic ester widely used in pharmaceutical excipients and polymer development. These innovations fully demonstrate YINO’s strength in green chemistry and sustainable material development.

YINO Biologic, a leading innovator in non-food bio-based materials, has reached a significant milestone in sustainability by obtaining its first Product Carbon Footprint (PCF) certification. Verified in strict accordance with ISO 14067:2018 standards, the certification systematically accounts for greenhouse gas emissions across the cradle-to-gate lifecycle—from raw material sourcing to plant delivery. This achievement underscores YINO Biologic’s commitment to green manufacturing, transparent disclosure, and low-carbon transformation in line with the global dual-carbon strategy and ESG priorities.

CPHI China 2025 marked more than a conclusion—it was a launchpad for future collaboration and global impact. Looking ahead, YINO Biologic will continue to advance non-food bio-based platform technologies, expand our global presence, and help shape a greener, more sustainable pharmaceutical solvent industry through high-performance, traceable, and low-carbon product solutions. We believe that green technology is more than a trend—it’s the foundation of trust, innovation, and growth. YINO Biologic is proud to stand at the intersection of science and sustainability, and we look forward to co-creating a healthier planet together with our global partners.

[May, 2025] Shandong YINO Bio-Group, a leading innovator in bio-based raw materials, has joined the United Nations Global Compact (UNGC), This milestone not only marks a significant step in YINO Bio-Group’s internationalization and globalization journey but also reflects international recognition of its relentless efforts in advancing sustainable development.

Exploring the path of green development from China to the world; From efficiency to effectiveness, practicing the wisdom of Chinese enterprises. Recently, Shandong Yino Biologic Materials Co., Ltd. was awarded a bronze medal certification by EcoVadis, a provider of corporate sustainability ratings!